住院患者鲍曼不动杆菌感染趋势调查  

Development of infection and drug-resistance of Acinetobacter baumannii

作　　者：李培兰[1] 林伟[1] 陈凌[1] 马玉珠[2] 王佩兰[2] 孟申[1] 

机构地区：[1]北京博爱医院内科,北京市100068 [2]北京博爱医院检验科,北京市100068

出　　处：《中国康复理论与实践》2005年第11期955-955,共1页Chinese Journal of Rehabilitation Theory and Practice

摘　　要：目的探讨鲍曼不动杆菌感染及耐药率的变迁。方法回顾分析我院2001-2005年6月住院患者鲍曼不动杆菌感染情况。结果鲍曼不动杆菌感染由2001年全年15株上升至2005年半年68株,高度耐药菌株由20%上升至77%。结论鲍曼不动杆菌感染率和耐药率的不断上升。Objective To investigate the recent development of Acinetobacter baumannii infection and its drug-resistance. Methods The Acinetobacter baumannii infections of inpatients during the year 2001 to June,2005 were analyzed retrospectively. Results The infection of Acinetobacter baumannii increased from 15 strains in 2001 to 68 strains in the first half of 2005. The rate of high drug-resistance strains also raised from 20% to 77 %. Conclusion The incident of infection of Acinetobacter baumannii continuously increased in the past 5 years and became more difficult to treat.

关 键 词：鲍曼不动杆菌 细菌感染 耐药率 抗生素 

分 类 号：R517.9[医药卫生—内科学]